STEFANO MARIOTTI

Prof. Dr. STEFANO MARIOTTI

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2018 in Seminars in Oncology
Verified
Journal Article
Closed access
CSCinzia Solinas
Cinzia Solinas
MPMichele Porcu
Michele Porcu
PSPushpamali De Silva
Pushpamali De Silva
MMMarco Musi
Marco Musi
SASandrine Aspeslagh
Sandrine Aspeslagh
Luca SabaLuca Saba
Luca Saba

6 October 2020 in Journal of Endocrinological Investigation
Verified
Journal Article
Closed access
PDF file
CPC. Piras
C. Piras
MPM. Pibiri
M. Pibiri
VLV. P. Leoni
V. P. Leoni
ABA. Balsamo
A. Balsamo
LTL. Tronci
L. Tronci
LAL. Atzori
L. Atzori

1 September 2022 in Cancers
Verified
Journal Article
Open access
PDF file
FPFabiana Pani
Fabiana Pani
PCPaola Caria
Paola Caria
YYYoshinori Yasuda
Yoshinori Yasuda
MMMakoto Miyara
Makoto Miyara
SMSTEFANO MARIOTTI
STEFANO MARIOTTI
CBCamille Buffet
Camille Buffet
Papillary thyroid cancer (PTC) often co-occurs with Hashimoto’s thyroiditis, an association that has long been reported in clinical studies, remaining controversial. Experimental evidence has recently shown that pre-existing thyroiditis has a beneficial effect on PTC growth and progression by a distinctive expansion of effector memory CD8 T cells. Although the link between inflammation and PTC might involve different components of the immune system, a deep characterization of them which includes T cells, B cells and tertiary lymphoid structures, Mye-loid cells, Neutrophils, NK cells and dendritic cells will be desirable. The present review article considers the role of the adaptive and innate immune response surrounding PTC in the context of Hashimoto’s thyroiditis. This review will focus on the current knowledge by in vivo and in vitro studies specifically performed on animals’ models; thyroid cancer cells and human samples including (i) the dual role of tumor-infiltrating lymphocytes; (ii) the emerging role of B cells and tertiary lymphoid structures; (iii) the role of myeloid cells, dendritic cells, and natural killer cells; (iv) the current knowledge of the molecular biomarkers implicated in the complex link between thyroiditis and PTC and the potential implication of cancer immunotherapy in PTC patients in the context of thyroiditis.

26 September 2013 in International Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
Pietro Giorgio CALO'Pietro Giorgio CALO'
Pietro Giorgio CALO'
Fabio MedasFabio Medas
Fabio Medas
GPGiuseppe Pisano
Giuseppe Pisano
FBFrancesco Boi
Francesco Boi
GBGermana Baghino
Germana Baghino
ANAngelo Nicolosi
Angelo Nicolosi
The aim of this retrospective study was to determine the rate of metastases in the central neck compartment and examine the morbidity and rate of recurrence in patients with differentiated thyroid cancer treated with or without a central neck dissection. Two hundred and fifteen patients undergoing total thyroidectomy with preoperative diagnosis of differentiated thyroid cancer, in the absence of suspicious nodes, were divided in two groups: those who underwent a thyroidectomy only (group A; ) and those who also received a central neck dissection (group B; ). Five cases (2.32%) of nodal recurrence were observed: 3 in group A and 2 in group B. Tumor histology was associated with a risk of recurrence: Hürthle cell-variant and tall cell-variant carcinomas were associated with a high risk of recurrence. Multifocality and extrathyroidal invasion also presented a higher risk, while smaller tumors were at lower risk. The results of this study suggest that prophylactic central neck dissection should be reserved for high-risk patients only. A wider use of immunocytochemical and genetic markers to improve preoperative diagnosis and the development of methods for the intraoperative identification of metastatic lymph nodes will be useful in the future for the improved selection of patients for central neck dissections.

1 June 2009 in Hormone Research in Paediatrics
Verified
Journal Article
Closed access
SMSTEFANO MARIOTTI
STEFANO MARIOTTI
APAlessia Prinzis
Alessia Prinzis
MGMariangela Ghiani
Mariangela Ghiani
VCValentina M. Cambuli
Valentina M. Cambuli
SPSabrina Pilia
Sabrina Pilia
SLSandro Loche
Sandro Loche
Background: Chronic autoimmune thyroiditis (CAT) displays a strong female predominance with female-to-male (F:M) ratios of 4–20:1 in adults and 2–9:1 in children and adolescents. Both genetic and hormonal factors are involved in this phenomenon. The relation between puberty and F:M ratio in CAT has never been evaluated. Methods: The F:M ratio of 133 children with CAT (group A, age at diagnosis 2.4–17.7 years) was compared with that of 113 adult CAT patients (group B, age at diagnosis 21–79 years). Group A included 64 prepubertal (aged 2.4–13.2 years, group A1) and 69 pubertal (aged 9.2–17.4, group A2) children. Results: The F:M ratio in group A was 3.0, which is significantly (p < 0.001) lower than that (10.3) found in group B patients. The F:M ratio of group A1 prepubertal children was lower (1.6) and significantly different from that of pubertal (6.7, p < 0.01) and adult patients (10.3, p < 0.0001). This phenomenon was more evident in hypothyroid as compared to euthyroid CAT. Conclusions: This study provides the first evidence that female predominance of CAT strongly increases during puberty, suggesting a major role for sex hormones in this phenomenon. Further studies are needed to clarify this point.

1 September 2018 in Clinical Colorectal Cancer
Verified
Journal Article
Closed access
MSMarta Schirripa
Marta Schirripa
GPGiuseppe Pasqualetti
Giuseppe Pasqualetti
RGRiccardo Giampieri
Riccardo Giampieri
MSMario Scartozzi
Mario Scartozzi
SLSara Lonardi
Sara Lonardi
FLFotios Loupakis
Fotios Loupakis